Received Nov 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 2 | — | IM |
Expiry date of 9/23/2025 and was administered to a patient on 9/26/2025; This non-serious spontaneous Safety Report was received with reference number: 02881645 (Interaction number: 02881638) by partner on 01-OCT-2025 and forwarded to agency on 01-OCT-2025 from a Health Professional Additional information for this case was received on 03-OCT-2025. Due to the nature of the event, the causality between Vaxelis and the event of "Expiry date of 9/23/2025 and was administered to a patient on 9/26/2025" was not applicable. Further information is not expected.
Infantile eczema; Prophylaxis
FLULAVAL; PREVNAR 20